FdaApplication
ANDA 220046
Identifiers
- fda_app_no: ANDA220046
Properties
| Property | Value |
|---|---|
| applicant_name | BPI LABS LLC |
| application_type | ANDA |
| approval_date | 2026-04-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FLUORESCEIN SODIUM | FLUORESCEIN SODIUM | EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | INJECTABLE;INTRAVENOUS |
1 product